CSF lactate levels in high risk neonates with and without asphyxia

Area of Science:

• Neonatal Medicine
• Neurology
• Biochemistry

Background:

• Birth asphyxia is a significant cause of neonatal morbidity and mortality.
• Cerebral hypoxia is a major complication of birth asphyxia.
• Accurate assessment of hypoxic injury severity is crucial for timely intervention.

Purpose of the Study:

• To determine the utility of cerebrospinal fluid (CSF) lactate levels in assessing the severity of cerebral hypoxia in neonates.
• To investigate the relationship between CSF lactate levels and gestational/postnatal ages.
• To identify factors associated with elevated CSF lactate in asphyxiated neonates.

Main Methods:

• CSF lactate levels were measured in 150 nonasphyxiated and 46 asphyxiated high-risk neonates.
• Statistical analysis was performed on log lactate levels, correlating them with gestational and postnatal ages.
• Incidence of CSF lactate elevation was compared between infants studied within and after eight hours of asphyxia, and in relation to term status, fetal distress, and Apgar scores.

Main Results:

• Log lactate levels in nonasphyxiated infants showed a significant relationship with gestational and postnatal ages.
• CSF lactate elevation was observed in 16/29 infants within eight hours of asphyxia, versus 0/17 studied after eight hours (P < .001).
• Higher incidence of elevated CSF lactate was noted in term infants (7/8), those with fetal distress (13/17), and very low Apgar scores (11/18). Seven of eight infants with markedly elevated lactate had both fetal distress and low Apgar scores.

Conclusions:

• CSF lactate determination in the immediate postasphyxial period is an objective method for assessing cerebral hypoxia severity.
• Early measurement of CSF lactate can help identify neonates with significant hypoxic brain injury.
• Findings highlight the importance of early assessment in managing neonates affected by birth asphyxia.